These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 9371067)

  • 1. Physicians, finder's fees and free, informed consent.
    Flegel KM
    CMAJ; 1997 Nov; 157(10):1373-4. PubMed ID: 9371067
    [No Abstract]   [Full Text] [Related]  

  • 2. Bounty-hunting and finder's fees.
    Christensen JA; Orlowski JP
    IRB; 2005; 27(3):16-9. PubMed ID: 16021797
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase I cancer trials. A collusion of misunderstanding.
    Miller M
    Hastings Cent Rep; 2000; 30(4):34-43. PubMed ID: 10971892
    [No Abstract]   [Full Text] [Related]  

  • 4. Research ethics and clinical trials: fostering collaboration with research participants.
    Phipps E; Fleetwood J; Piraino A
    Account Res; 1999; 6(3):215-26. PubMed ID: 11658125
    [No Abstract]   [Full Text] [Related]  

  • 5. An application of moral guidelines in human clinical trials to a study of a benzodiazepine compound as a hypnotic agent among the elderly.
    Axelsen D; Wiggins RA
    Clin Res; 1977 Jan; 25(1):1-7. PubMed ID: 10314392
    [No Abstract]   [Full Text] [Related]  

  • 6. Finder's fees for research subjects.
    Lind SE
    N Engl J Med; 1990 Jul; 323(3):192-5. PubMed ID: 2362609
    [No Abstract]   [Full Text] [Related]  

  • 7. The patient as partner: ethics in clinical oncology research.
    Veatch RM
    Johns Hopkins Med J; 1982 Oct; 151(4):155-61. PubMed ID: 7120718
    [No Abstract]   [Full Text] [Related]  

  • 8. Ethical issues in psychotherapy research. Problems in a collaborative clinical trials study.
    Imber SD; Glanz LM; Elkin I; Sotsky SM; Boyer JL; Leber WR
    Am Psychol; 1986 Feb; 41(2):137-46. PubMed ID: 3516035
    [No Abstract]   [Full Text] [Related]  

  • 9. Can patients be asked to pay for experimental treatment?
    Lind SE
    Clin Res; 1984 Oct; 32(4):393-8. PubMed ID: 6509865
    [No Abstract]   [Full Text] [Related]  

  • 10. Finder's fees may compromise the provider-patient relationship.
    McGough H
    IRB; 1991; 13(1-2):23. PubMed ID: 11653979
    [No Abstract]   [Full Text] [Related]  

  • 11. Competing clinical trials in the same institution: ethical issues in subject selection and informed consent.
    Gordon EJ; Micetich KC
    IRB; 2002; 24(2):1-7. PubMed ID: 12374154
    [No Abstract]   [Full Text] [Related]  

  • 12. Informed consent in medical experimentation.
    Burgess MM
    Ann R Coll Physicians Surg Can; 1987 Jan; 20(1):29-31. PubMed ID: 11649817
    [No Abstract]   [Full Text] [Related]  

  • 13. Making research a requirement of treatment: why we should sometimes let doctors pressure patients to participate in research.
    Orentlicher D
    Hastings Cent Rep; 2005; 35(5):20-8. PubMed ID: 16295261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ethics of deception in biomedical research.
    Sharpe G; Weisstub DN
    Health Law Can; 1996 May; 16(4):101-10. PubMed ID: 10173418
    [No Abstract]   [Full Text] [Related]  

  • 15. Why I oppose drug company payment of physician/investigators on a per patient/subject basis.
    Roizen R
    IRB; 1988; 10(1):9-10. PubMed ID: 11658990
    [No Abstract]   [Full Text] [Related]  

  • 16. Power, advocacy, and informed consent forms.
    Smith ML
    J Calif Alliance Ment Ill; 1994; 5(1):25-7. PubMed ID: 11653311
    [No Abstract]   [Full Text] [Related]  

  • 17. Recruitment for clinical trials: the need for public-professional co-operation.
    Gillon R
    J Med Ethics; 1994 Mar; 20(1):3-4. PubMed ID: 8035436
    [No Abstract]   [Full Text] [Related]  

  • 18. Empirical research on informed consent. An annotated bibliography.
    Sugarman J; McCrory DC; Powell D; Krasny A; Adams B; Ball E; Cassell C
    Hastings Cent Rep; 1999; 29(1):S1-42. PubMed ID: 10051999
    [No Abstract]   [Full Text] [Related]  

  • 19. Investigator financial disclosures and its effect on research subjects.
    Gibbs JN; Guagnano GA
    Food Drug Law J; 2007; 62(4):727-37. PubMed ID: 18557228
    [No Abstract]   [Full Text] [Related]  

  • 20. Is the practice of offering finder's fees for subject recruitment appropriate? Is the practice widespread or unique to my institution? What is the proper role of the IRB? What is the role of the institution?
    IRB; 1990; 12(4):6. PubMed ID: 11651263
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.